DEFA14A: Leap Therapeutics Corrects Proxy Card Ahead of July 2 Annual Meeting

Leap Therapeutics issues a supplement to its proxy statement to correct an administrative error on the proxy card related to the election of directors.

Summary

• Leap Therapeutics has filed a proxy statement supplement to correct an error on the proxy card for its upcoming annual meeting of shareholders.
• The error involved Proposal No.
• 1, the election of directors, which incorrectly provided shareholders with the option to 'Abstain' from voting.
• The corrected proxy card will only offer 'For' or 'Withhold' options for voting on the election of directors.
• The company has provided a revised proxy card to shareholders of record.
• Shareholders can change their votes until 11:59 p.m.
• Eastern Time on July 1, 2024.
• The annual meeting is scheduled for July 2, 2024.

Sentiment

Score: 7

Explanation: The document is a neutral announcement regarding a procedural correction. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The company is proactively addressing and correcting an error in its proxy materials.
• Shareholders are being provided with a revised proxy card and clear instructions on how to vote.
• The correction ensures that shareholder votes are accurately recorded and reflect their intentions.

Risks

• The administrative error could have caused confusion among shareholders regarding the voting options for the election of directors.
• Failure to correct the error could have led to challenges regarding the validity of the vote on Proposal No.
• 1.

Future Outlook

The document does not contain any specific forward-looking statements regarding financial performance or business strategy beyond the procedural aspects of the annual meeting.

Industry Context

This announcement is a routine procedural update related to corporate governance and shareholder voting, common among publicly traded companies preparing for annual meetings.

Stakeholder Impact

• Shareholders are directly impacted by the correction to the proxy card, as it affects their ability to vote accurately.
• The correction ensures that the annual meeting proceeds smoothly and that shareholder votes are properly counted.

Next Steps

• Shareholders should review the revised proxy card and submit their votes by the deadline.
• The company will hold its annual meeting on July 2, 2024.

Key Dates

Keywords

proxy statement, Leap Therapeutics, annual meeting, election of directors, proxy card, shareholders, voting, corporate governance